SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-016497
Filing Date
2019-03-05
Accepted
2019-03-05 16:27:40
Documents
1
Period of Report
2018-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9851
  Complete submission text file 0001209191-19-016497.txt   11401
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address
Pedder Simon (Reporting) CIK: 0001316736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38112 | Film No.: 19658800